Aerovate Therapeutics Inc (AVTE)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 77.68M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
0
52W High
$ 102.31
52W Low
$ 61.90
Dividend Yield
0.00%
Beta
0.95
Technicals
50-Day MA
88.739
200-Day MA
82.1782
52 Week High
102.3135
52 Week Low
61.8996
About AVTE
Aerovate Therapeutics, Inc., a biopharmaceutical company, engages in the treatment of pulmonary arterial hypertension in the United States.
Employees
4
Headquarters
Waltham, MA
CEO
Mr. Timothy P. Noyes M.B.A.
Latest News
New virtual platform for veterinary technician educators to come - DVM360
3 weeks ago • Google News
Aerovate Therapeutics Inc. (AVTE) Announces 1-for-35 Reverse Stock Split - AInvest
2025-04-28 • Google News